Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael A. Carducci Eric J Small Mark J Ratain Michael J. Morris Michael Kelley Susan Halabi |
| Publication date | November 21, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |